The Institute of Health Metrics and Evaluation is hosting a research conference on population health metrics and the future directions of this emerging field. The two-day event starts on April 10 and is co-sponsored by the Seattle, USA-based IHME and The Lancet.
"There's a lot of good work being doing out there, but it's being done by many groups who don't talk to each other...and who use different yardstcks to assess their efforts," IHME director Christopher Murray told local newspaper, the Seattle Post-Intelligencer. Together with Alan Lopez, Dr Murray helped establish the landmark Global Burden of Disease methods and applications, a new metric that compared death and disability from various diseases and the contribution of risk factors to the overall burden of disease in developing and developed countries, helping to refine health care funding criteria. Although health spending accounts for 9% of world economic output, the IHME says there is a lack of objective, comparable and comprehensible information available to policymakers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze